Michael Crump

Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.

L. Tye, P. Goss, D. Walde, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.